Hackensack University Medical Center - John Theurer Cancer Center is a clinical research site located in Hackensack, New Jersey, United States 07601.
Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
Hackensack University Medical Center - John Theurer Cancer Center has participated in 14 clinical trials with 5 currently active.
Therapeutic areas: Multiple Myeloma, Relapsed/Refractory Peripheral T-Cell Lymphoma, Adult T Cell Leukemia/Lymphoma.
Sponsors: Karyopharm Therapeutics Inc, Daiichi Sankyo, NovoCure Ltd..
Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Hackensack University Medical Center - John Theurer Cancer Center has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Hackensack University Medical Center - John Theurer Cancer Center has 14 clinical trials on record, with 5 currently active. Their work covers Multiple Myeloma, Relapsed/Refractory Peripheral T-Cell Lymphoma, Adult T Cell Leukemia/Lymphoma.
Yes — Hackensack University Medical Center - John Theurer Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.